Skip to main content

Table 2 Efficacy of treatment between the studied groups

From: Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms

Variables

Total (n = 53)

Group A (n = 26)

Group B (n = 27)

p value

Spasm frequency before treatment/day

   

0.842

 Mean ± SD

20.55 ± 4.37

20.42 ± 3.92

20.67 ± 4.84

 Min–max

13–27

14–27

13–27

Spasms cessation at 7 days

28 (52.8)

14 (53.8)

14 (51.9)

1.000

Spasms cessation at 14 days

21 (39.6)

10 (38.5)

11 (40.7)

1.000

Recurrence at 6 weeks

7 (13.2)

3 (11.5)

4 (14.8)

1.000

EEG* improvement at 2 weeks

20 (37.7)

11 (42.3)

9 (33.3)

0.577

EEG* improvement at 6 weeks

25 (47.2)

12 (46.2)

13 (48.1)

1.000

  1. Values present as mean ± SD were analyzed by Mann–Whitney U-test
  2. Values present as number and percent were analyzed by Fisher’s exact test
  3. *Electroencephalogram